| 亞諾法生技近期推出由 GMP 認證合格的工廠製造出的 20 個免疫組化單株抗體，符合美國體外檢驗試劑（IVD class I）的規範。這些抗體經過免疫組化的應用測試可做為生物標記（biomarkers），用於一般的研究及臨床研究來分析各種組織及疾病。這 20 個抗體的推出不只表示亞諾法的產品已能達到更好的品質，同時也代表了亞諾法跨足到體外檢驗試劑（IVD）市場的第一步。我們將會更盡心盡力製作出更合乎臨床應用的單株抗體，讓您的研究更上一層樓！ |
 ACTN4 (Human lung adenocarcinoma) |
 ANXA5 (Human colon cancer) |
 CDH17 (Human colon cancer) |
 CLDN1 (Human colon cancer) |
 CTH (Human liver) |
 EGR1 (Human colon cancer) |
 EIF2C2 (Human stomach) |
 ENO1 (Human lymphoma) |
 FOXC2 (Human lung carcinoma) |
 GBA (Human breast cancer) |
 HMGB1 (Human colon cancer) |
 HSD3B1 (Human placenta) |
 PGR (Human breast cancer) |
 SALL4 (Human testis) |
 SPINK1 (Human prostate cancer) |
 STIP1 (Human ovarian cancer) |
 TARDBP (Human pancreas) |
 TFF3 (Human colon cancer) |
 TUBA1B (Human breast cancer) |
 YAP1 (Human ovary cancer) |
 |
